Demidem A, Chiller J M, Kanagawa O
Lilly Research Laboratories, La Jolla, San Diego, California 92037.
Transplantation. 1990 May;49(5):966-71. doi: 10.1097/00007890-199005000-00025.
Cultured neonatal epidermal cells or sheets have been grafted successfully onto allogeneic recipients across an MHC barrier, while genetically identical skin allografts were rejected. Induction of specific allosensitization by prior priming with allogeneic spleen cells or allogeneic skin grafts did not prejudice the survival of subsequent cultured epidermal allografts. When cultured epidermis and adult skin of the same genotype were grafted simultaneously, as double grafts, cultured epidermis survived despite the presence of an ongoing allograft rejection reaction in the host. Furthermore, pretreatment of the recipients with cultured epidermis failed to protect against rejection of subsequent allogeneic adult skin grafts of the same genetic origin. These data indicate that cultured epidermis is neither immunogenic nor antigenic in allogeneic host. In companion experiments it was determined that neonatal (noncultured) epidermal allografts also survived indefinitely, implying that neonatal epidermis lacks antigenicity. However, in contrast to cultured epidermis, neonatal epidermal allografts evoked specific systemic immunity in their recipients, since they rejected a subsequent allogeneic adult skin grafts in accelerated fashion. These data demonstrate that in neonatal epidermis antigenicity can be dissociated from immunogenicity.
培养的新生表皮细胞或表皮片已成功移植到跨越主要组织相容性复合体(MHC)屏障的同种异体受体上,而基因相同的皮肤同种异体移植物则被排斥。用同种异体脾细胞或同种异体皮肤移植物预先致敏诱导特异性同种异体致敏,并不影响随后培养的表皮同种异体移植物的存活。当将相同基因型的培养表皮和成年皮肤作为双移植物同时移植时,尽管宿主中存在正在进行的同种异体移植排斥反应,但培养的表皮仍能存活。此外,用培养表皮对受体进行预处理,未能防止随后相同遗传来源的同种异体成年皮肤移植物被排斥。这些数据表明,培养的表皮在同种异体宿主中既无免疫原性也无抗原性。在相关实验中确定,新生(未培养的)表皮同种异体移植物也能无限期存活,这意味着新生表皮缺乏抗原性。然而,与培养表皮不同的是,新生表皮同种异体移植物在其受体中引发了特异性全身免疫,因为它们以加速方式排斥随后的同种异体成年皮肤移植物。这些数据表明,在新生表皮中,抗原性可以与免疫原性分离。